UniSa - IRIS Institutional Research Information System

MAGLIO, ANGELANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.955
NA - Nord America 1.666
EU - Europa 842
SA - Sud America 158
Continente sconosciuto - Info sul continente non disponibili 75
AF - Africa 37
OC - Oceania 8
Totale 7.741
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 4.001
US - Stati Uniti d'America 1.601
IT - Italia 472
SG - Singapore 451
CN - Cina 154
VN - Vietnam 132
BR - Brasile 115
RU - Federazione Russa 109
BD - Bangladesh 55
DE - Germania 54
FR - Francia 49
IN - India 47
IE - Irlanda 32
CA - Canada 28
MX - Messico 22
GB - Regno Unito 18
KR - Corea 18
TR - Turchia 17
AR - Argentina 16
FI - Finlandia 15
ES - Italia 14
IQ - Iraq 14
JP - Giappone 14
NL - Olanda 14
ZA - Sudafrica 14
PL - Polonia 12
UA - Ucraina 12
CO - Colombia 10
SE - Svezia 9
AT - Austria 7
AU - Australia 7
CR - Costa Rica 6
ID - Indonesia 6
PK - Pakistan 6
EG - Egitto 5
SA - Arabia Saudita 5
CZ - Repubblica Ceca 4
EC - Ecuador 4
GY - Guiana 4
PH - Filippine 4
TT - Trinidad e Tobago 4
UZ - Uzbekistan 4
VE - Venezuela 4
AZ - Azerbaigian 3
BG - Bulgaria 3
DZ - Algeria 3
GR - Grecia 3
IL - Israele 3
JM - Giamaica 3
KE - Kenya 3
KW - Kuwait 3
LT - Lituania 3
MY - Malesia 3
NP - Nepal 3
TN - Tunisia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
ET - Etiopia 2
KG - Kirghizistan 2
LB - Libano 2
MA - Marocco 2
PE - Perù 2
PY - Paraguay 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
EE - Estonia 1
EU - Europa 1
LK - Sri Lanka 1
LY - Libia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
SC - Seychelles 1
SI - Slovenia 1
SV - El Salvador 1
YE - Yemen 1
Totale 7.667
Salva come PNG Salva come JPEG
Città #
Hong Kong 3.997
San Jose 259
Singapore 250
Ashburn 177
Milan 144
Chandler 127
Council Bluffs 111
Dallas 103
Ann Arbor 70
Beijing 62
Princeton 57
Naples 56
Lauterbourg 41
Los Angeles 41
Rome 39
New York 38
Santa Clara 37
Ho Chi Minh City 31
Dublin 29
Munich 29
Hanoi 27
Moscow 25
Woodbridge 24
The Dalles 21
Jacksonville 18
Dong Ket 17
Salerno 17
Phoenix 15
Pune 15
Denver 14
Pollena Trocchia 14
Frankfurt am Main 13
Orem 13
São Paulo 13
Chicago 12
Izmir 12
Montreal 12
Mexico City 11
San Francisco 11
Tokyo 11
Warsaw 11
Atlanta 10
Boardman 10
Boston 10
Da Nang 10
Johannesburg 10
Memphis 10
Baghdad 9
Houston 9
Turku 9
Brooklyn 8
Buffalo 8
Seattle 8
Turin 8
Wilmington 8
Chennai 7
Acerra 6
Bologna 6
Campobasso 6
Dearborn 6
Haiphong 6
Mumbai 6
New Delhi 6
Amsterdam 5
Andover 5
Avellino 5
London 5
Nuremberg 5
Redwood City 5
Rio de Janeiro 5
Sarno 5
Stockholm 5
Toronto 5
Bari 4
Brasília 4
Castellammare di Stabia 4
Charlotte 4
Figino 4
Georgetown 4
Grammichele 4
Nanjing 4
Ninh Bình 4
Poplar 4
San José 4
Sydney 4
Trani 4
Verona 4
Vienna 4
Birmingham 3
Brno 3
Curitiba 3
Dhaka 3
Florence 3
Foggia 3
Helsinki 3
Kathmandu 3
Kuwait City 3
Nairobi 3
Osio Sotto 3
Querétaro 3
Totale 6.346
Salva come PNG Salva come JPEG
Nome #
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 901
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 710
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 600
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma 573
Effects of inhaled beclomethasone dipropionate/formoterol fumarate/glycopyrronium on diaphragmatic workload and lung function in uncontrolled asthma: a case report 486
Acute Coronary Syndrome in patients with SARS-CoV-2 infection: Pathophysiology and Translational Perspectives 461
Phenotyping severe asthma: a rationale for biologic therapy 433
Novel Biological Therapies for Severe Asthma Endotypes 245
Pharmacotherapeutic strategies for critical asthma syndrome: a look at the state of the art 205
Age as a risk factor in the occurrence of pneumothorax after transthoracic fine needle biopsy: our experience 180
Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy 164
SIRT1 Activity in Peripheral Blood Mononuclear Cells Correlates with Altered Lung Function in Patients with Chronic Obstructive Pulmonary Disease 139
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems 130
Activation of the AIM2 Receptor in Circulating Cells of Post-COVID-19 Patients With Signs of Lung Fibrosis Is Associated With the Release of IL-1α, IFN-α and TGF-β 129
Diagnostic yield and safety of C-TBNA in elderly patients with lung cancer. 125
Chronic obstructive pulmonary disease and heart failure: Common diseases of the elderly, frequent non-recognition and the value of specialist referral 115
Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting 114
Mindfulness-Based Interventions for Chronic Pulmonary Diseases: A Systematic Review of Effects on Anxiety, Depression, Stress, Dyspnea, and Quality of Life 114
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 113
Tezepelumab: A potential new biological therapy for severe refractory asthma 107
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study 95
Effect of the Arg16Gly β2-Adrenergic Receptor Polymorphism on Long-Term Mepolizumab Response and Clinical Remission in Severe Eosinophilic Asthma: A Genotype-Stratified, Multicenter Study 94
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 94
Real-life effectiveness of mepolizumab on forced expiratory flow between 25% and 75% of forced vital capacity in patients with severe eosinophilic asthma 93
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13 90
Post-COVID-19 Patients Who Develop Lung Fibrotic-like Changes Have Lower Circulating Levels of IFN-β but Higher Levels of IL-1α and TGF-β 89
DPO: DIFFUSE PULMONARY OSSIFICATION - A DIAGNOSTIC CHALLENGE 87
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 84
Compendio di malattie dell'apparato respiratorio 81
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets 77
Achieving sustained remission in severe asthma: goals, challenges, issues and opportunities 72
Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy 65
Prevalence of Persistent Olfactory Disorders in Patients With COVID-19: A Psychophysical Case-Control Study With 1-Year Follow-up 65
Design per una nuova cultura della prevenzione 63
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study 62
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 62
THE MANY FACES OF COVID-19: ORGANIZING PNEUMONIA (OP) PATTERN HRCT FEATURES 58
Key role of thymic stromal lymphopoietin as a molecular target for biologic treatment of severe asthma 49
Effects of Pulmonary Rehabilitation on Dyspnea, Quality of Life and Cognitive Function in COPD: A Systematic Review 41
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis 39
Biologic Therapy in Severe Asthma: A Phenotype-Driven and Targeted Approach 31
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 31
Real-World Efficacy of Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium on Diaphragmatic Workload Assessed by Ultrasound and Lung Function in Patients with Uncontrolled Asthma 29
SIRT 1 and oxidative stress in COPD pathogenesis 28
Arg16Gly 132-Adrenoreceptor Polymorphism in Severe EosinophilicAsthma: Implications for Mepolizumab Long-Term Effectiveness and Clinical Remission 27
Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients? 26
Obesity and respiratory function impairment in asthmatic and non asthmatic children 24
Effects of Tezepelumab in “United Airway Disease” (Asthma and CRSwNP) 18
Predictive Factors And Treatments Associated with Clinical Remission in Severe Eosinophilic Asthma 12
Assessing response to biological therapies in severe asthma 11
Totale 7.741
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.031
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.031
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022108 0 0 3 1 0 7 12 3 10 5 21 46
2022/2023290 18 40 26 38 22 51 8 26 25 6 20 10
2023/2024215 16 15 9 12 6 41 11 40 4 13 9 39
2024/2025534 7 8 10 24 18 56 130 21 70 31 62 97
2025/20266.064 963 1.996 1.277 171 282 130 329 78 212 253 115 258
2026/2027266 91 124 51 0 0 0 0 0 0 0 0 0
Totale 7.741